Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-01-07 @ 12:09 AM
Study NCT ID:
NCT03185494
Status:
UNKNOWN
Last Update Posted:
2019-04-17
First Post:
2017-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-06-10
First Submit QC Date:
None
Study First Post Date:
2017-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-16
Last Update Post Date:
2019-04-17
Last Update Post Date Type:
ACTUAL